For the first clinical trials of COVAXINE, Belagavi’s Jeevan Rekha Hospital getting ready, COVAXIN to arrive Jeevan Rekha Hospital within 4-5 days.
The first phase of the Covaxin trials are to be conducted on 375 participants across 12 clinical trial sites in the country. Jeevan Rekha Hospital is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin. Healthy volunteers having no co-morbid conditions and without a history of Covid-19, aged more than 18 years and less than 55 years, would be eligible to participate in the randomised, double-blind, placebo-controlled clinical trial.
AIIMS Patna was the first institute to start the trial on Wednesday and has so far vaccinated around nine people with a smaller dose to check for safety, two sources said, on condition of anonymity. After two weeks, if the vaccine is found to be safe it will be given to more people, the sources said.
If everything goes as per plan Jeevan Rekha Hospital in Belagavi to begin clinical trials by 10-12 days